Q2 2025 Medifast Inc Earnings Call Transcript
Key Points
- Medifast Inc (MED) reported revenue and EPS above guidance for the second quarter of 2025.
- The company introduced a new pricing and incentive structure called Premier Plus, simplifying the value proposition for clients and making it easier for coaches to attract and retain clients.
- Medifast Inc (MED) launched the Edge program to provide integrated coach incentives and best practices, aiming to simplify onboarding and enhance coach productivity.
- The company maintains a strong financial position with $162.7 million in cash and no interest-bearing debt as of June 30, 2025.
- Medifast Inc (MED) is focusing on metabolic health, addressing a significant market need with 93% of US adults being metabolically unhealthy.
- Revenue for the second quarter decreased by 37.4% compared to the previous year, primarily due to a decline in the number of active earning OPTAVIA coaches.
- The total number of coaches decreased by 32.7% from the second quarter of 2024.
- Average revenue per active earning OPTAVIA Coach decreased by 6.9% year-over-year.
- The company experienced a loss from operations of $1.1 million in the second quarter of 2025.
- Medifast Inc (MED) provided guidance for the third quarter with expected revenue ranging from $70 million to $90 million and earnings per share potentially resulting in a loss.
Greetings, and welcome to the Medifast second-quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce you to your host, Steven Zenker, the Investor Relations. Thank you, Steven. You may begin
Good afternoon, and welcome to Medifast second-quarter 2025 earnings conference call. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer.
By now, everyone should have access to the earnings release for the second quarter ended June 30, 2025, that went out this afternoon at approximately 4:05 PM Eastern time. If you have not received the release, it is available on the Investor Relations portion of Medifast website at www.medifastinc.com. This call is being webcast, and a replay will also be available on the company's website.
Before we begin, we would
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
